Author: Adam Gutbezahl

Impact on Employers of the FDA Approval of the Pfizer-BioNTech COVID-19 Vaccine

The U.S. Food and Drug Administration (“FDA”) recently approved use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of the COVID-19 disease in individuals 16 years of age or older. Previously, all COVID-19 vaccinations administered in the United States were approved through Emergency Use Authorization (“EUA”), which enables the FDA to allow for use of…

Read More

POSTED IN: COVID-19, Employment Law, News

Vaccinations in the Workplace: What Can Be Required of Employees

The “new normal” following the COVID-19 pandemic appears just across the horizon. The number of active COVID-19 cases continues to decline. Traffic is increasing. The sun is coming out and temperatures are rising (aside from Memorial Day weekend). This return to normalcy is helped in great part by the large number of people in the Bay…

Read More

POSTED IN: COVID-19, Employment Law

COVID-19 Vaccinations in the Employment Setting

Over the last week, the United States saw a heartening advancement in the COVID-19 situation: the distribution and administration of a vaccine.  This exciting development suggests a return to “normal” may, in fact, be on the horizon.  At the same time, many questions remain concerning the COVID-19 vaccination in the employment context.  Can an employer…

Read More

POSTED IN: COVID-19, Employment Law, News